{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:01:42Z","timestamp":1784613702838,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00428-014-1559-9","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T11:37:34Z","timestamp":1393328254000},"page":"495-503","source":"Crossref","is-referenced-by-count":44,"title":["In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor"],"prefix":"10.1007","volume":"464","author":[{"given":"Ling","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Hyjek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Schuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"1559_CR1","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","volume":"186","author":"FX McCormack","year":"2012","unstructured":"McCormack FX, Travis WD, Colby TV, Henske EP, Moss J (2012) Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. Am J Respir Crit Care Med 186:1210\u20131212","journal-title":"Am J Respir Crit Care Med"},{"key":"1559_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1183\/09059180.00011010","volume":"20","author":"S Harari","year":"2011","unstructured":"Harari S, Torre O, Moss J (2011) Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev 20:34\u201344","journal-title":"Eur Respir Rev"},{"key":"1559_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/09059180.00000311","volume":"20","author":"V Cottin","year":"2011","unstructured":"Cottin V, Archer F, Leroux C, Mornex JF, Cordier JF (2011) Milestones in lymphangioleiomyomatosis research. Eur Respir Rev 20:3\u20136","journal-title":"Eur Respir Rev"},{"key":"1559_CR4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack FX (2008) Lymphangioleiomyomatosis: a clinical update. Chest 133:507\u2013516","journal-title":"Chest"},{"key":"1559_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10038-002-8651-8","volume":"47","author":"T Sato","year":"2002","unstructured":"Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, Fukuchi Y, Hino O (2002) Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 47:20\u201328","journal-title":"J Hum Genet"},{"key":"1559_CR6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","volume":"167","author":"M Karbowniczek","year":"2003","unstructured":"Karbowniczek M, Astrinidis A, Balsara BR, Testa JR, Lium JH, Colby TV, McCormack FX, Henske EP (2003) Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 167:976\u2013982","journal-title":"Am J Respir Crit Care Med"},{"key":"1559_CR7","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","volume":"101","author":"DM Crooks","year":"2004","unstructured":"Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP Jr, Wang JA, Kumaki F, Darling T, Moss J (2004) Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 101:17462\u201317467","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1559_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","volume":"67","author":"VJ Ferrans","year":"2000","unstructured":"Ferrans VJ, Yu ZX, Nelson WK, Valencia JC, Tatsuguchi A, Avila NA, Riemenschn W, Matsui K, Travis WD, Moss J (2000) Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J Nippon Med Sch 67:311\u2013329","journal-title":"J Nippon Med Sch"},{"key":"1559_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","volume":"21","author":"Y Matsumoto","year":"1999","unstructured":"Matsumoto Y, Horiba K, Usuki J, Chu SC, Ferrans VJ, Moss J (1999) Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 21:327\u2013336","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1559_CR10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00000478-199311000-00002","volume":"17","author":"F Bonetti","year":"1993","unstructured":"Bonetti F, Chiodera P, Pea M, Martignoni G, Bosi F, Zamboni G, Mariuzzi GM (1993) Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB-45 for diagnosis. Am J Surg Pathol 17:1092\u20131102","journal-title":"Am J Surg Pathol"},{"key":"1559_CR11","first-page":"732","volume":"118","author":"V Hoon","year":"1994","unstructured":"Hoon V, Thung SN, Kaneko N, Unger PD (1994) HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med 118:732\u2013734","journal-title":"Arch Pathol Lab Med"},{"key":"1559_CR12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","volume":"52","author":"X Zhe","year":"2004","unstructured":"Zhe X, Schuger L (2004) Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis. J Histochem Cytochem 52:1537\u20131542","journal-title":"J Histochem Cytochem"},{"key":"1559_CR13","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","volume":"24","author":"A Astrinidis","year":"2005","unstructured":"Astrinidis A, Henske EP (2005) Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene 24:7475\u20137481","journal-title":"Oncogene"},{"key":"1559_CR14","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","volume":"2","author":"DJ Kwiatkowski","year":"2005","unstructured":"Kwiatkowski DJ, Manning BD (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2:R251\u2013R258","journal-title":"Hum Mol Genet"},{"key":"1559_CR15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345\u20131356","journal-title":"N Engl J Med"},{"key":"1559_CR16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejim.2007.10.015","volume":"19","author":"DW Hohman","year":"2008","unstructured":"Hohman DW, Noghrehkar D, Ratnayake S (2008) Lymphangioleiomyomatosis: A review. Eur J Intern Med 19:319\u2013324","journal-title":"Eur J Intern Med"},{"key":"1559_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00408-008-9087-5","volume":"186","author":"D Chorianopoulos","year":"2008","unstructured":"Chorianopoulos D, Stratakos G (2008) Lymphangioleiomyomatosis and tuberous sclerosis complex. Lung 186:197\u2013207","journal-title":"Lung"},{"key":"1559_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","volume":"34","author":"I Bittman","year":"2003","unstructured":"Bittman I, Rolf B, Amann G, Lohrs U (2003) Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. Hum Pathol 34:95\u201398","journal-title":"Hum Pathol"},{"key":"1559_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1164\/ajrccm.163.1.2005004","volume":"163","author":"GD Strizheva","year":"2001","unstructured":"Strizheva GD, Carsillo T, Kruger WD, Sullivan EJ, Ryu JH, Henske EP (2001) The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med 163:253\u2013258","journal-title":"Am J Respir Crit Care Med"},{"key":"1559_CR20","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP (2000) Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 97:6085\u20136090","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1559_CR21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Slegtenhorst van","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"1559_CR22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"European chromosome 16 tuberous sclerosis consortium","year":"1993","unstructured":"European chromosome 16 tuberous sclerosis consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315","journal-title":"Cell"},{"key":"1559_CR23","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.C300226200","volume":"278","author":"AF Castro","year":"2003","unstructured":"Castro AF, Rebhun JF, Clark GG, Quilliam LA (2003) Rheb binds TSC2 and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 278:32493\u201332496","journal-title":"J Biol Chem"},{"key":"1559_CR24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G (2003) Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11:1457\u20131466","journal-title":"Mol Cell"},{"key":"1559_CR25","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17:1829\u20131834","journal-title":"Genes Dev"},{"key":"1559_CR26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D et al (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5:578\u2013581","journal-title":"Nat Cell Biol"},{"key":"1559_CR27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1042\/BST0390466","volume":"39","author":"R Tomasoni","year":"2011","unstructured":"Tomasoni R, Mondino A (2011) The tuberous sclerosis complex: balancing proliferation and survival. Biochem Soc Trans 39:466\u2013471","journal-title":"Biochem Soc Trans"},{"key":"1559_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN (2008) Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358:140\u2013151","journal-title":"N Engl J Med"},{"key":"1559_CR29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K (2011) Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364:1595\u20131606","journal-title":"N Engl J Med"},{"key":"1559_CR30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","volume":"154","author":"AM Taveira-DaSilva","year":"2011","unstructured":"Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J (2011) Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. Ann Intern Med 154:797\u2013805","journal-title":"Ann Intern Med"},{"key":"1559_CR31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.rmed.2008.11.007","volume":"103","author":"MM Cohen","year":"2009","unstructured":"Cohen MM, Freyer AM, Johnson SR (2009) Pregnancy experiences among women with lymphangioleiomyomatosis. Respir Med 103:766\u2013772","journal-title":"Respir Med"},{"key":"1559_CR32","first-page":"182","volume":"12","author":"S Saleh Gargari","year":"2009","unstructured":"Saleh Gargari S, Hantoushzadae S, Mohamadi F, Jafar-Abadi M (2009) Pregnancy complicated by lymphangioleiomyomatosis. Arch Iran Med 12:182\u2013185","journal-title":"Arch Iran Med"},{"key":"1559_CR33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/thorax.57.12.1085","volume":"57","author":"S Yano","year":"2002","unstructured":"Yano S (2002) Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment. Thorax 57:1085\u20131086","journal-title":"Thorax"},{"key":"1559_CR34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.161.3.9904009","volume":"161","author":"K Matsui","year":"2000","unstructured":"Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, Ferrans VJ (2000) Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med 161:1002\u20131009","journal-title":"Am J Respir Crit Care Med"},{"key":"1559_CR35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/hupa.2000.18500","volume":"31","author":"K Matsui","year":"2000","unstructured":"Matsui K, Tatsuguchi A, Valencia J, Zx Y, Bechtle J, Beasley MB, Avila N, Travis WD, Moss J, Ferrans VJ (2000) Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol 31:1242\u20131248","journal-title":"Hum Pathol"},{"key":"1559_CR36","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/AJCPPC9EX1ZHMRMA","volume":"135","author":"RJ Flavin","year":"2011","unstructured":"Flavin RJ, Cook J, Fiorentino M, Bailey D, Brown M, Loda MF (2011) \u03b2-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis. Am J Clin Pathol 135:776\u2013782","journal-title":"Am J Clin Pathol"},{"key":"1559_CR37","first-page":"564260","volume":"2011","author":"T Wakamiya","year":"2011","unstructured":"Wakamiya T, Sugita Y, Hashiguchi M, Iwasaka T, Tokunaga O (2011) Tuberous sclerosis complex associated with papillary serous carcinoma of the peritoneum, lymphangioleiomyomatosis, and angiomyolipoma. Case Report Pathol 2011:564260","journal-title":"Case Report Pathol"},{"key":"1559_CR38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000325340","volume":"53","author":"K Mitani","year":"2009","unstructured":"Mitani K, Kumasaka T, Takemura H, Hayashi T, Gunji Y, Kunogi M, Akiyoshi T, Takahashi K, Suda K, Seyama K (2009) Cytologic, immunocytochemical and ultrastructural characterization of lymphangioleiomyomatosis cell clusters in chylous effusions of patients with lymphangioleiomyomatosis. Acta Cytol 53:402\u2013409","journal-title":"Acta Cytol"},{"key":"1559_CR39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1620\/tjem.199.119","volume":"199","author":"LH Pan","year":"2003","unstructured":"Pan LH, Ito H, Kurose A, Yamauchi K, Inoue H, Sawai T (2003) Pulmonary lymphangioleiomyomatosis: a case report with immunohistochemical details and DNA analysis. Tohoku J Exp Med 199:119\u2013126","journal-title":"Tohoku J Exp Med"},{"key":"1559_CR40","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","volume":"106","author":"JJ Yu","year":"2009","unstructured":"Yu JJ, Robb VA, Morrison TA, Ariazi EA, Karbowniczek M, Astrinidis A, Wang C, Hernandez-Cuebas L, Seeholzer LF, Nicolas E, Hensley H, Jordan VC, Walker CL, Henske EP (2009) Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc Natl Acad Sci U S A 106:2635\u20132640","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1559_CR41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.115.1.276","volume":"115","author":"X Denoo","year":"1999","unstructured":"Denoo X, Hermans G, Degives R, Foidart JM (1999) Successful treatment of pulmonary lymphangioleiomyomatosis with progestins: a case report. Chest 115:276\u2013279","journal-title":"Chest"},{"key":"1559_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/S1806-37132011000300015","volume":"37","author":"BG Baldi","year":"2011","unstructured":"Baldi BG, Medeiros Junior P, Pimenta SP, Lopes RI, Kairalla RA, Carvalho CR (2011) Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis. J Bras Pneumol 37:375\u2013379","journal-title":"J Bras Pneumol"},{"key":"1559_CR43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.07-2277","volume":"133","author":"S Harari","year":"2008","unstructured":"Harari S, Cassandro R, Chiodini I, Taveira-DaSilva AM, Moss J (2008) Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. Chest 133:448\u2013454","journal-title":"Chest"},{"key":"1559_CR44","first-page":"39","volume":"24","author":"M Schiavina","year":"2007","unstructured":"Schiavina M, Contini P, Fabiani A, Cinelli F, Di Scioscio V, Zompatori M, Campidelli C, Pileri SA (2007) Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients. Sarcoidosis Vasc Diffuse Lung Dis 24:39\u201350","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1559_CR45","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","volume":"126","author":"AM Taveira-DaSilva","year":"2004","unstructured":"Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J (2004) Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 126:1867\u20131874","journal-title":"Chest"},{"key":"1559_CR46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-199909000-00004","volume":"78","author":"T Urban","year":"1999","unstructured":"Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, Cordier JF (1999) Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies \"Orphelines\" Pulmonaires (GERM\"O\"P). Medicine (Baltimore) 78:321\u2013337","journal-title":"Medicine (Baltimore)"},{"key":"1559_CR47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1471-2407-12-262","volume":"12","author":"YJ Liang","year":"2012","unstructured":"Liang YJ, Hao Q, Zhang HM, Wu YZ, Wang JD (2012) Insulin-like growth factors in endometrioid adenocarcinoma: correlation with clinico-pathological features and estrogen receptor expression. BMC Cancer 12:262","journal-title":"BMC Cancer"},{"key":"1559_CR48","doi-asserted-by":"crossref","first-page":"473572","DOI":"10.1155\/2012\/473572","volume":"2012","author":"C Mufudza","year":"2012","unstructured":"Mufudza C, Sorofa W, Chiyaka ET (2012) Assessing the effects of estrogen on the dynamics of breast cancer. Comput Math Methods Med 2012:473572","journal-title":"Comput Math Methods Med"},{"key":"1559_CR49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm.187.6.663","volume":"187","author":"KR Badri","year":"2013","unstructured":"Badri KR, Gao L, Hyjek E, Schuger N, Schuger L, Qin W, Chekaluk Y, Kwiatkowski DJ, Zhe X (2013) Exonic mutations of TSC2\/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis (LAM). Am J Respir Crit Care Med 187:663\u2013665","journal-title":"Am J Respir Crit Care Med"},{"key":"1559_CR50","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","volume":"286","author":"J Yu","year":"2004","unstructured":"Yu J, Astrinidis A, Howard S, Henske EP (2004) Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol 286:L694\u2013L700","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1559_CR51","first-page":"201","volume":"27","author":"SH Ueng","year":"2004","unstructured":"Ueng SH, Liu HP, Wu YC, Tsai YH, Lin HC, Lin MC, Lim KE, Huang SF (2004) Pulmonary lymphangioleiomyomatosis: a clinicopathological analysis of ten cases. Chang Gung Med J 27:201\u2013209","journal-title":"Chang Gung Med J"},{"key":"1559_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1746-1596-7-27","volume":"7","author":"A Laurinavicius","year":"2012","unstructured":"Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J (2012) Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol 7:27","journal-title":"Diagn Pathol"},{"key":"1559_CR53","doi-asserted-by":"crossref","first-page":"e30840","DOI":"10.1371\/journal.pone.0030840","volume":"7","author":"PH Horst van der","year":"2012","unstructured":"van der Horst PH, Wang Y, Vandenput I, K\u00fchne LC, Ewing PC, van Ijcken WF, van der Zee M, Amant F, Burger CW, Blok LJ (2012) Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer. PLoS One 7:e30840","journal-title":"PLoS One"},{"key":"1559_CR54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.18632\/oncotarget.201","volume":"1","author":"Y Wang","year":"2010","unstructured":"Wang Y, van der Zee M, Fodde R, Blok LJ (2010) Wnt\/\u0392-Catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 1:674\u2013684","journal-title":"Oncotarget"},{"key":"1559_CR55","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-09-0814","volume":"15","author":"Y Wang","year":"2009","unstructured":"Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, Veldscholte J, van Doorn HC, Ewing PC, Kim JJ, Grootegoed JA, Burger CW, Fodde R, Blok LJ (2009) Progesterone inhibition of Wnt\/beta-catenin signaling in normal endometrium and endometrial cancer. Clin Cancer Res 15:5784\u20135793","journal-title":"Clin Cancer Res"},{"key":"1559_CR56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1677\/ERC-08-0244","volume":"16","author":"C Lanari","year":"2009","unstructured":"Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC, Giulianelli S, Cerliani JP, Wargon V, Molinolo A (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333\u2013350","journal-title":"Endocr Relat Cancer"},{"key":"1559_CR57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women\u2019s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"1559_CR58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419\u2013427","journal-title":"Lancet"},{"key":"1559_CR59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2011.09.021","volume":"357","author":"SD Axlund","year":"2012","unstructured":"Axlund SD, Sartorius CA (2012) Progesterone regulation of stem and progenitor cells in normal and malignant breast. Mol Cell Endocrinol 357:71\u201379","journal-title":"Mol Cell Endocrinol"},{"key":"1559_CR60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/eem.11.25","volume":"6","author":"AR Daniel","year":"2011","unstructured":"Daniel AR, Hagan CR, Lange CA (2011) Progesterone receptor action: defining a role in breast cancer. Expert Rev Endocrinol Metab 6:359\u2013369","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1559_CR61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/carcin\/bgr303","volume":"33","author":"M Riggio","year":"2012","unstructured":"Riggio M, Polo ML, Blaustein M, Colman-Lerner A, L\u00fcthy I, Lanari C, Novaro V (2012) PI3K\/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer. Carcinogenesis 33:509\u2013518","journal-title":"Carcinogenesis"},{"key":"1559_CR62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/me.2002-0318","volume":"17","author":"X Cui","year":"2003","unstructured":"Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV (2003) Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Mol Endocrinol 17:575\u2013588","journal-title":"Mol Endocrinol"},{"key":"1559_CR63","first-page":"177","volume":"21","author":"TW Grunt","year":"2012","unstructured":"Grunt TW, Mariani GL (2012) Targeting the PI3K\/AKT\/mTOR pathway in breast cancer. Curr Cancer Drug Targets 21:177\u2013184","journal-title":"Curr Cancer Drug Targets"},{"key":"1559_CR64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2010.12.006","volume":"126","author":"Y Xie","year":"2011","unstructured":"Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, Liao QP (2011) Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. J Steroid Biochem Mol Biol 126:113\u2013120","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1559-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1559-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1559-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:36:13Z","timestamp":1559079373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1559-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1559-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}